This browser is no longer supported at MarketWatch. Privacy Notice, and An easy decision Is Mid Penn Bancorp (MPB) A Good Stock To Buy? Bristol-Myers Squibb (BMY) Catches Eye: Stock Jumps 6.8% Bristol-Myers Squibb Company BMY was a big mover last session, as the company saw its shares rise nearly 7% on the day. Something went wrong while loading Watchlist. There are currently no items in this Watchlist. Is Platinum Group Metals Limited (PLG) A Good Stock To Buy? In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. Its shares trade at only a little over eight times expected earnings -- well below most of its peers. Its shares trade at only a little over eight times expected earnings -- well below most of its peers. View the latest Bristol Myers Squibb Co. (BMY) stock price, news, historical charts, analyst ratings and financial information from WSJ. Intraday Data provided by FACTSET and subject to terms of use. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. By using this site you agree to the Bristol-Myers Squibb Germany Sie können sich an unseren EU-Datenschutzbeauftragten unter EUDPO@BMS.com wenden, um Ihre Datenschutzrechte auszuüben und um Ihre Bedenken oder Fragen in Bezug auf den Umgang mit Ihren personenbezogenen Daten durch die Bristol-Myers Squibb GmbH & Co. KGaA zu äußern. Cookie Notice. Why Did Warren Buffett’s Berkshire Hathaway Fall Out of Love With JPMorgan? All rights reserved. While Bristol Myers Squibb stock has rallied by about 40% since its March lows, it still appears reasonably valued, trading at just about 10x projected … 63.05 0.00 (0.00%)After hours: 3:26PM EST, Subscribe to Premium to view Fair Value for BMY. Have Watchlists? In aggregate, Bristol Myers Squibb currently has a Value Score of B, putting it into the top 40% of all stocks we cover from this look. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always […], Analyst Report: Bristol-Myers Squibb Company. Bristol Myers (BMY) obtains EC approval for Opdivo as a second-line treatment for unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma. The company was founded in August 1933 and is headquartered in New York, NY. Has Buffett Become an Expert on Big Pharma? © 2020 Verizon Media. Get Bristol-Myers Squibb Co (BMY:NYSE) real-time stock quotes, news and financial information from CNBC. Subscriber Agreement & Terms of Use, BMY | Complete Bristol Myers Squibb Co. stock news by MarketWatch. Bristol-Myers Squibb Contingent Value Rights: Inspection Could Be Taking Place Or Imminent. Week’s Best: Wealth Apps Have Room for Improvement, The lines for COVID-19 tests are longer than the lines for Black Friday shopping, 7 Questions for the Most Powerful Woman in Tech, Oil prices end mixed Friday but both grades log sharp weekly gain, Kodiak Sciences, Playa Hotel See Activist Action, Man who called Dow 20,000 says 3 factors will make 2021 ‘a very good year’ for stocks, Three paths Exxon could take with its dividend, Here are key reasons bitcoin prices are tumbling, and the bullish factors that may buoy them, Schrödinger to receive $55 mln upfront from Bristol Myers, up to $2.7 bln in milestone payments and royalties, Schrödinger announces multi-target drug discovery agreement with Bristol Myers, Bristol Myers sees 2020 adj. Bristol-Myers Squibb's (NYSE:BMY) Stock Price Has Reduced 11% In The Past Five Years By Simply Wall St Published November 01, 2020. Log in to see them here or sign up to get started. This Expansion Still Looks Self-Sustaining, Says One Economist, Bristol Myers Stock Is Rising Because the Celgene Drugs It Acquired Boosted Earnings, Bristol Myers Squibb's stock gains with Eliquis sales jumping 9% during the third quarter, Revance's (RVNC) DaxibotulinumtoxinA BLA Decision Delayed, Biotech Stock Roundup: REGN's Cocktail Gets EUA, GILD & AMGN Provide Updates & More, Bristol Myers' (BMY) Opdivo Wins EC Nod for Esophageal Cancer, Tracking David Abrams' Abrams Capital Management Portfolio - Q3 2020 Update, Bristol Myers wins EU approval of Opdivo for esophageal cancer, Final Market Comments (Goodbye To Seeking Alpha), Schrödinger stock scales, upgraded by BofA after collaboration with BMY, Schrödinger inks multi-target drug discovery deal with Bristol-Myers Squibb, Bristol Myers Squibb: A Classic Buffett Style 'Fat Pitch', Bristol-Myers Squibb: CEO Giovanni Caforio At The Wolfe Research Healthcare Conference, Jim Simons' Firm's Top 5 Sells of the 3rd Quarter, Top Research Reports for Bank of America, Broadcom & Lowe's, Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio Presents at Wolfe Research Healthcare Conference (Transcript), Bristol-Myers Squibb Continues On Its Path To Becoming The Next Quarter Trillion-Dollar Company, Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS, Veeva Systems (VEEV) Boosts Portfolio of Cloud-Based Offerings, OncoSec: Undervalued And Continuing To Make Progress, Bristol Myers' (BMY) CAR T-Cell Therapy BLA Review Delayed. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's giving away his top pick for free right here. BMY: Get the latest Bristol-Myers Squibb stock price and detailed information including BMY news, historical charts and realtime prices. Get today's Bristol Myers Squibb Co Rights stock price and latest BMY_r news as well as Bristol Myers Rights real-time stock quotes, technical analysis, full financials and more. Shares of Bristol Myers Squibb Co. BMY, +1.38% rallied 1.38% to $64.50 Monday, on what proved to be an all-around favorable trading session for the stock … Discover new investment ideas by accessing unbiased, in-depth investment research, NYSE - NYSE Delayed Price. Visit a quote page and your recently viewed tickers will be displayed here. Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Bristol Myers Squibb offers a current dividend yield of 3% against the S&P 500 s average of about 2%. Bristol-Myers Squibb (BMY) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes. Intraday data delayed at least 15 minutes or per exchange requirements. Bristol Myers Squibb Co. stock rises Monday, outperforms market, Bristol Myers Squibb Co. stock outperforms market on strong trading day, Bristol Myers Squibb Co. stock falls Thursday, underperforms market, No Stimulus? Create a list of the investments you want to track. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. View real-time stock prices and stock quotes for a full financial overview.